WO2008058715A1 - Cosmetic formulation containing glucosyl glycerides and cationic emulsifiers - Google Patents

Abstract

The invention relates to a cosmetic preparation containing a combination of a) one or more cationic emulsifiers and b) one or more glucosyl glycerides.

Description

 description

Cosmetic formulation with glucosylglycerides and cationic emulsifiers

The present invention relates to cosmetic preparation with cationic emulsifiers and one or more glucosylglycerides.

The desire to look beautiful and attractive is inherently rooted in man. Although the ideal of beauty has undergone changes over time, the pursuit of an impeccable appearance has always been the goal of man. An essential part of a beautiful and attractive appearance is the condition and appearance of the skin.

For the skin to fulfill its biological functions to the full extent, it needs regular cleaning and care. Cleansing of the skin serves to remove dirt, sweat and remnants of dead skin particles, which form an ideal breeding ground for pathogens and parasites of all kinds. Skin care products are mostly used for

Moisturizing and moisturizing the skin. Often, agents that regenerate the skin and, for example, prevent and reduce their premature aging (e.g., wrinkles, wrinkles) are added to them.

Among the ingredients used in cosmetics include u.a. Glucosylglyceride. They moisturize the skin and enhance its barrier function. However, the prior art preparations containing glucosylglycerides have the disadvantage of leaving a sticky skin feeling on and after application to the skin when the active ingredient is used in higher concentrations (greater than 2% by weight).

It was therefore the object of the present invention to eliminate the disadvantages of the prior art and to develop glucosylglycosides containing cosmetic preparations which leave no sticky impression even at higher active ingredient content (greater than 2 wt .-%) during and after application to the skin.

Surprisingly, the object is achieved by a cosmetic preparation containing a combination of one or more cationic emulsifiers and one or more glucosylglycerides.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation according to the invention contains the glucosylglyceride (s) in a concentration of 0.01 to 10% by weight, preferably in a concentration of 0.05 to 6% by weight and more preferably in a concentration from 0.1 to 3% by weight, based in each case on the total weight of the preparation.

It is advantageous according to the invention if one or more cationic emulsifiers are selected from the group of the compounds dimethyldioctadecylammonium chloride, dicocoylethylhydroxyethylmonium methosulfate, dicetyldimonium chloride, behentrimonium chloride, lauryltrimonium chloride, dipalmitoylethyldimonium chloride, N- (2-hydroxyhexadecyl-1) -N, N-dimethyl-N-2. hydroxyethylammonium chloride, distearoylethylhydroxyethylmonium methosulfate, tris (oligooxyethyl) alkylammonium phosphate, dicocoylethylhydroxyethylmonium methosulfate and / or cetyltrimethylammonium chloride.

It is particularly preferred according to the invention, if as a cationic emulsifier

Dimethyldioctadecylammonium chloride is used.

It is advantageous according to the invention if the preparation according to the invention is cationic

Emulsifiers in a total amount of 0.05 to 10% by weight, and preferably in one

Concentration of 0.5 to 5.0% by weight, based in each case on the total weight of

Preparation included.

It is particularly preferred according to the invention, if as a cationic emulsifier

Dimethyldioctadecylammonium chloride is used.

For the purposes of the present invention, glucosylglycerols of the formula are advantageous

und/oderand or

and or

und/oder

and or

Although in the prior art DE 195 40 749 and unpublished DE 10 2005 023634, DE10 2005 023635, DE10 2005 023636, DE10 2005 023637, DE10 2005 023638, DE10 2005 023639, DE10 2005 023640, DE10 2005 023641, DE 10 2006 034530.4 and DE 20 2006 011472.6, and JP 2004-331581, JP 2004-331576, JP 2004-331578, JP 2004-331579, JP 2004-331580, JP 2004-331582, JP 2004-331583, which are incorporated herein by reference However, these writings could not point the way to the present invention

According to the invention, the preparation according to the invention is present in the form of an emulsion.

It is advantageous for the purposes of the present invention if the preparation according to the invention contains cationic polymers.

It is preferred according to the invention if as cationic polymers one or more compounds selected from the group of the compounds of the cationic cellulose derivatives, cationic starch derivatives, quaternized vinylpyrrolidone / vinylimidazole copolymers are used.

It is advantageous according to the invention if the preparation according to the invention comprises cationic polymers in a total amount of 0.05 to 2.5% by weight and preferably in a concentration of 0.1 to 1.5% by weight, based in each case on the total weight of the preparation ,

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation contains one or more further UV filters selected from the group of the compounds phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5 tetrasulfonic acid salts; -2-Phenyl-benzimidazole-5-sulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bornylidenemethyl) benzene and its salts; 4- (2-oxo-3-bomylidenemethyl) benzene sulfonic acid salts; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid salts; 2,2'-methylene-bis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol); 2- (2H-Benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-i - [(trimethylsilyl) oxy] disiloxanyl] propyl] -phenol ; 3- (4-methylbenzylidene) camphor; 3-benzylidenecamphor; ethylhexyl salicylate; Terephthalidendicamphersulfonsäure; 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester; 4- (dimethylamino) benzoic acid amyl ester; 4-Methoxybenzalmalon-säuredi (2-ethylhexyl) ester; 4-methoxycinnamic acid (2-ethylhexyl) ester; Isoamyl 4-methoxycinnamate; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone;2,2'-dihydroxy-4-methoxybenzophenone; Hexyl 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoate, 4- (tert-butyl) -4'-methoxydibenzoylmethane;homomenthyl; 2-ethylhexyl 2-hydroxybenzoate; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate; dimethicodiethylbenzalmalonate; 3- (4- (2,2-bisethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane / dimethylsiloxane copolymer; 2,4-Bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine) ; Dioctylbutylamidotriazone (INCI: diethylhexylbutamidotriazone); 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine having the (CAS Nos 288254-16-0); 4,4- ^l , 4 "- (1, 3,5-triazine-2 ₎ 4,6-triyltriimino) -tris-benzoic acid tris (2-ethylhexyl ester) (external: 2,4,6-tris) anilino (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCl: ethylhexyl triazone); 2,4,6-tribiphenyl-4-yl-1,3, 5-triazine; merocyanines; titanium dioxide; zinc oxide in a concentration of 0.01 to 40% by weight and preferably in a concentration of 1 to 20% by weight, based on the total weight of the preparation.

It is advantageous according to the invention if the preparation according to the invention is free of p-methylbenzylidene camphor. The pigments (titanium dioxide, zinc oxide) can advantageously also be used in the form of commercially available oily or aqueous predispersions in the context of the present invention. Advantageously, dispersants and / or solubilizers can be added to these predispersions.

According to the invention, the pigments (titanium dioxide, zinc oxide) can advantageously be surface-treated ("coated"), in which case for example a hydrophilic, amphiphilic or hydrophobic character is to be formed or is to be retained.This surface treatment can consist in that the pigments are prepared by processes known per se be provided with a thin hydrophilic and / or hydrophobic inorganic and / or organic layer.The various surface coatings may also contain water for the purposes of the present invention.

Inorganic surface coatings for the purposes of the present invention may consist of aluminum oxide (Al ₂ O ₃ ), aluminum hydroxide Al (OH) ₃ or aluminum oxide hydrate (also: Alumina, CAS No .: 1333-84-2), sodium hexametaphosphate (NaPO ₃ ) ₆ , sodium metaphosphate (NaPO ₃ ) _n , silica (SiO ₂ ) (also: silica, CAS No .: 7631-86-9), barium sulfate (BaSO ₄ ) or iron oxide (Fe ₂ O ₃ ). These inorganic surface coatings may occur alone, in combination and / or in combination with organic coating materials.

Organic surface coatings for the purposes of the present invention may consist of vegetable or animal aluminum stearate, vegetable or animal stearic acid, lauric acid, dimethylpolysiloxane (also: dimethicone), methylpolysiloxane (methicone), simethicone (a mixture of dimethylpolysiloxane with an average chain length of 200 to 350 Dimethylsiloxane units and silica gel) or alginic acid. These organic surface coatings may be present alone, in combination and / or in combination with inorganic coating materials.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation according to the invention contains one or more compounds selected from the group consisting of parabens, phenoxyethanol, ethylhexylglycerol, 2-methylpropane-1, 3-diol, butylene glycol, propylene glycol, which are present in a total concentration of 0.01 to 10% by weight, based on the total weight of the preparation may be present in this.

According to the invention, the preparation according to the invention contains as further ingredients one or more compounds selected from the group of the compounds folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, camitin, polydocanol, natural and / or synthetic isoflavonoids, in particular genistein, flavonoids, carotenoids, creatine, creatinine, taurine, ascorbic acid + derivatives of oxygen, tocopherol + esters, dihydroxyacetone; 8-hexadecene-1, 16-dicarbonsäü ^'re, the long as well as short-chain hyaluronic acid (that is, hyaluronic acid having an average molecular weight of 1 million to 3 million Daltons, such as also 5000 Daltons - 1 million Daltons) and / or licochalcone A. Such ingredients can each be contained in a single concentration of 0.01 to 10% by weight, based on the total weight of the preparation in this. Particularly preferred according to the invention is the use of carnitine.

It is inventively advantageous if the preparation according to the invention in addition

Urea in a concentration of 0.01 to 50% by weight, preferably in a concentration of 0.1 to 20% by weight and more preferably in a concentration of 1 to 15% by weight based on the total weight of the preparation contains.

Furthermore, the preparations according to the invention may also advantageously contain repellents for protection against mosquitoes, ticks and spiders and the like. Advantageous z. N, N-diethyl-3-methylbenzamide (trade name: "DEET"), dimethyl phthalate (trade name: Palatinol M, DMP), 1-piperidinecarboxylic acid 2- (2-hydroxyethyl) -1-methylpropyl ester, and especially 3- (Nn Butyl-N-acetyl-amino) -propionic acid ethyl ester (available commercially from Merck under the tradename Insekt Repellent® 3535.) The repellents can be used either singly or in combination.

Moisturizers are substances or mixtures of substances which give cosmetic preparations the property of reducing the moisture release of the hom layer (also called transepidermal water loss (TEWL) after application or spreading on the skin surface) and / or hydrating the homschicht positively influence.

Advantageous humectants (moisturizers) for the purposes of the present invention are, for example, glycerol, lactic acid and / or lactates, in particular sodium lactate, butylene glycol, propylene glycol, panthenol, biosaccharide gum-1, glycine soya, ethylhexyloxyglycerol, pyrrolidonecarboxylic acid and hyaluronic acid. Furthermore, it is particularly advantageous to use polymeric moisturizers from the group of water-soluble and / or water-swellable and / or water-gellable polysaccharides. For example, a fucose-rich polysaccharide which is particularly advantageous in the

Chemical Abstracts filed under the registry number 178463-23-5 and z. B. under the name Fucogel®1000 of the company SOLABIA SA is available. Moisturizers can advantageous as anti-wrinkle active ingredients to protect against skin changes, as they are, for. B. occur during skin aging, can be used.

It is advantageous for the purposes of the present invention, when the inventive preparation one or more humectants in a total concentration of 0.1 to 20% by weight and preferably in a total concentration of 0.5 to 10% by weight, each based on the total weight of Preparation containing.

The cosmetic preparations according to the invention may also advantageously, although not necessarily, contain fillers which are e.g. B. the sensory and cosmetic

Further improve the properties of the formulations and, for example, cause or enhance a velvety or silky feel on the skin. Advantageous fillers for the purposes of the present invention are starch and starch derivatives (such as, for example, tapioca starch, distarch phosphate, aluminum or sodium starch, octenylsuccinate and the like), pigments which have neither mainly UV filter nor coloring action (such as, for example, US Pat. B. boron nitride etc.) and / or Aerosils ^® (CAS no. 7631-86-9) and / or talc.

The aqueous phase of the preparations according to the invention may advantageously comprise customary cosmetic auxiliaries, for example alcohols, in particular those of low C number, preferably ethanol and / or isopropanol, diols or polyols of low C number and their ethers, preferably propylene glycol, 2-methylpropane-1, 3-diol, ethylene glycol, ethylene glycol monomethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products, polymers, foam stabilizers, electrolytes and in particular one or more thickeners, which are advantageously selected may be selected from the group silicon dioxide, aluminum silicates, polysaccharides or their derivatives, for. As hyaluronic acid, xanthan gum, carrageenans, hydroxypropylmethylcellulose, particularly advantageous from the group of polyacrylates, preferably a polyacrylate from the group of so-called carbopols, for example Carbopols types 980, 981, 1382, 2984, 5984, each individually or in combination nation. Other thickeners which are advantageous according to the invention are those having the INCI name Acrylates / CIO-30 Alkyl Acrylate Crosspolymer (eg Pemulen TR 1, Pemulen TR 2, Carbopol 1328 from NOVEON) and Aristoflex AVC (INCI: Ammonium Acryloyl Dimethyl Taurate / VP copolymer).

According to the invention, the preparation according to the invention advantageously contains film formers. Film formers in the context of the present invention are substances of different composition, which are characterized by the following property: If a film former is dissolved in water or other suitable solvents and the solution is then applied to the skin, it forms after evaporation of the solvent, a film which essentially serves to fix the light filters on the skin and thus to increase the water resistance of the product.

It is particularly advantageous to use the film formers from the group of polymers based on polyvinylpyrrolidone (PVP).

zu wählen. Besonders bevorzugt sind Copolymere des Polyvinylpyrrolidons, beispielsweise das PVP Hexadecen Copolymer und das PVP Eicosen Copolymer, welche unter den Handelsbezeichnungen Antaron V216 und Antaron V220 bei der GAF Chemicals Cooperation erhältlich sind.

to choose. Particularly preferred are copolymers of polyvinylpyrrolidone, for example the PVP hexadecene copolymer and the PVP eicosene copolymer, which are available under the trade names Antaron V216 and Antaron V220 in the GAF Chemicals Cooperation.

Also advantageous are other polymeric film formers, such as sodium polystyrene sulfonate, sold under the tradename Flexan 130 at National Starch and Chemical Corp. and / or polyisobutene, available from Rewo under the tradename Rewopal PIB1000. Other suitable polymers are e.g. Polyacrylamides (Seppigel 305), polyvinyl alcohols, PVP, PVP / VA copolymers, polyglycols, acrylate / octylacralymide copolymer (Dermacryl 79). Also advantageous is the use of hydrogenated castor oil Dimerdilinoleat (CAS 646054-62-8, INCI Hydrogenated Castor OiI Dimer Dilinoleate), which can be purchased from Kokyu Alcohol Kogyo under the name Risocast DA-H or PPG-3 Benzylethermyristat ( CAS 403517-45-3), which can be obtained under the trade name Crodamol STS from Croda Chemicals.

The oil phase of the preparation according to the invention is advantageously selected from the group of polar oils, for example from the group of lecithins and fatty acid triglycerides, namely the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 8 to 24, in particular 12 to 18 C atoms. The fatty acid triglycerides can be selected, for example, advantageously from the group of synthetic, semi-synthetic and natural oils, such as. B. cocoglyceride, olive oil, sunflower oil, jojoba oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil,

Wheat germ oil, grapeseed oil, safflower oil, evening primrose oil, macadamia nut oil and the like.

Also advantageous according to the invention are z. As natural waxes of animal and vegetable origin, such as beeswax and other insect waxes and berry wax, shea butter and / or lanolin (wool wax). 8th In the context of the present invention, further advantageous polar oil components can furthermore be selected from the group of esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of from 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols of a chain length of 3 to 30 carbon atoms and from the group of esters of aromatic carboxylic acids and saturated and / or. unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms. Such ester oils can then advantageously be selected from the group consisting of phenethyl benzoate, 2-phenylethyl benzoate, isopropyl lauroyl sarcosinate, phenyl trimethicone, cyclomethicone, dibutyl adipate, octyl palmitate, octyl cocoate, octyl isostearate,

Octyldodeceyl myristate, octyldodecanol, cetearyl isononanoate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2- Octyl dodecyl palmitate, stearyl heptanoate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, tridecyl stearate, tridecyl trimellitate, as well as synthetic, semi-synthetic and natural mixtures of such esters, such as, for example, B. jojoba oil.

Furthermore, the oil phase can be advantageously selected from the group of dialkyl ethers and dialkyl carbonates, advantageous z. B. dicaprylyl ether (Cetiol OE) and / or dicaprylyl, for example, that available under the trade name Cetiol CC in the company. Cognis.

It is further preferred that tylglykoldiheptanoat or oil components from the group consisting of isoeicosane, neopentyl, propylene glycol dicaprylate / dicaprate, caprylic / capric / diglyceryl succinate, butylene glycol dicaprylate / dicaprate, C ₁₂ -i ₃ alkyl lactate, di-C ₁₂ - ₁₃ -Alkyltartrat, Triisostearin, dipentaerythrityl hexacaprylate / hexacaprate, propylene glycol monoisostearate, tricaprylin, dimethylisorboride. It is particularly advantageous if the oil phase of the formulations of the invention has a content of Ci ₂ -is-alkyl benzoate or consists entirely of this.

Advantageous oil components are also z. Butyloctyl salicylate (for example that available under the trade name Hallbrite BHB from the company CP HaJI), tridecyl salicylate (which is available under the trade name Cosmacol ESI from the company Sasol), C12-C15

Alkyl salicylate (available under the trade name Dermol NS from Alzo), hexadecyl benzoate and butyl octyl benzoate and mixtures thereof {Hallstar AB) and / or diethylhexyl naphthalate {Hallbrite TQ or Corapan TQ from Symrise).

Any mixtures of such oil and wax components are also advantageous to use in the context of the present invention. Furthermore, the oil phase can also advantageously contain non-polar oils, for example those which are selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, Vaseline (petrolatum), paraffin oil, squalane and squalene, polyolefins, hydrogenated polyisobutenes, C13- 16 isoparaffin and isohexadecane. Among the polyolefins, polydecenes are the preferred substances.

The preparations according to the invention can furthermore advantageously comprise one or more substances from the following group of siloxane elastomers, for example in order to increase the water resistance and / or the sun protection factor of the products: (a) siloxane elastomers which contain the units R ₂ SiO and RSiOi, ₅ and / or R ₃ SiO ₀ , s and / or SiO ₂ , wherein the individual radicals R are each independently hydrogen, Ci_ ₂₄ alkyl (such as methyl, ethyl, propyl) or aryl (such as phenyl or ToIyI), alkenyl (such as mean vinyl) and the weight ratio of the units R ₂ SiO RSiO to _{1, 5} from the range from 1: 1 to 30: 1 is selected;

(b) Siloxane elastomers which are insoluble and swellable in silicone oil obtainable by the addition reaction of an organopolysiloxane (1) containing silicon-bonded hydrogen with an organopolysiloxane (2) containing unsaturated aliphatic groups, the proportions used being such be such that the amount of hydrogen of the organopolysiloxane (1) or the unsaturated aliphatic groups of the organopolysiloxane (2)

In the range of 1 to 20 mol%, if the organopolysiloxane is not cyclic and

In the range of 1 to 50 mol%, when the organopolysiloxane is cyclic.

Advantageously in the context of the present invention, the siloxane elastomer (s) are in the form of spherical powders or in the form of gels.

Advantageously present in the form of spherical powder siloxane elastomers are those with the INCI name Dimeticone / Vinyl Dimeticone Crosspolymer, for example, that available from Dow Corning under the trade names Dow Corning 9506 Powder available.

It is particularly preferred if the siloxane elastomer is used in combination with oils of hydrocarbons of animal and / or vegetable origin, synthetic oils, synthetic esters, synthetic ethers or mixtures thereof. Particularly advantageous preparations are also obtained when antioxidants are used as additives or active ingredients. According to the invention, the preparations advantageously contain one or more antioxidants. As favorable, but nevertheless optional to be used antioxidants all suitable or common for cosmetic applications antioxidants can be used.

Particularly advantageous for the purposes of the present invention, water-soluble antioxidants can be used, such as vitamins, eg. As ascorbic acid and its derivatives.

Further preferred antioxidants are vitamin E and its derivatives as well as vitamin A and its derivatives.

The amount of the antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30 wt .-%, particularly preferably 0.05 to 20 wt .-%, in particular 0.1 to 10 wt .-%, based on the total weight the preparation.

If vitamin E and / or its derivatives represent the antioxidant (s), it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation.

If vitamin A or vitamin A derivatives, or carotenes or derivatives thereof, are the antioxidant (s), it is advantageous if their respective concentrations are in the range from 0.001 to 10% by weight, based on the total weight of the formulation choose.

It is particularly advantageous if the cosmetic preparations according to the present invention contain cosmetic active ingredients, where preferred active ingredients are antioxidants which can protect the skin against oxidative stress.

Inventive formulations which z. B. known anti-wrinkle active ingredients such as flavone glycosides (especially α-glycosyl rutin), coenzyme Q10, retinol and esters, vitamin E and / or derivatives and the like, are particularly advantageous for protection against aesthetically unattractive skin lesions as z. Skin aging (such as dryness, roughness, dryness wrinkles, itching, decreased refatting (eg, after washing), visible vascular dilation (telangiectasia, cuperosis), slackness and wrinkle and wrinkle formation, localized hypersensitivity). , Hypo and false pigmentation (eg, age spots), increased susceptibility to mechanical stress (eg, cracking), and the like) and tired skin. Furthermore, they are advantageously suitable against the appearance of dry or rough Skin.

The cosmetic Zubereitunge ^'h according to the invention can comprise cosmetic auxiliaries such as those conventionally used in such preparations,. Preservatives, preservatives, complexing agents, bactericides, perfumes, substances for preventing or increasing foaming, dyes, pigments which have a coloring effect, thickeners, moisturizing and / or moisturizing substances, fillers which improve the feel on the skin, fats, oils, Waxes or other common ingredients of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.

Advantageous in the context of the present invention are preparations for the care of the skin: they can serve the cosmetic sunscreen, as well as make-up product in decorative cosmetics.

According to their structure, cosmetic compositions according to the present invention, for example, be used as a skin protection cream, day or night cream, etc. It may be possible and advantageous to use the compositions of the invention as a basis for pharmaceutical formulations.

It is also advantageous in the context of the present invention to prepare cosmetic preparations whose main purpose is not the protection from sunlight, but which nevertheless contain a content of UV protective substances. So z. B. in day creams or makeup products usually incorporated UV-A or UV-B filter substances. Also UV protection substances, as well as antioxidants and, if desired, preservatives, an effective protection of the preparations themselves against spoilage. Also favorable are cosmetic preparations which are in the form of a sunscreen.

In particular, according to the invention, the use of the preparation according to the invention for protection against aging of the skin (in particular for protection against UV-induced aging of the skin) and as a sunscreen agent.

According to the invention, the preparation according to the invention advantageously has a pH of 5 to 8. This can be adjusted by the conventional acids, bases and buffer systems.

According to the invention, the use of the erfindungemäßen preparations for the prophylaxis and treatment of wrinkles and wrinkles. According to the invention, the use of the preparations according to the invention for the repair of the skin.

For use, the cosmetic preparations according to the invention are applied to the skin and / or the hair in a sufficient amount in the manner customary for cosmetics.

Examples The following examples are intended to illustrate the present invention without limiting it. Unless indicated otherwise, all amounts, proportions and percentages are based on the weight and the total amount or on the total weight of the preparations.

O / W emulsions

O/W-Emulsionen

O / W emulsions

O/W-Emulsionen

O / W emulsions

Claims

claims 1. A cosmetic preparation containing a combination of a) one or more canonical emulsifiers and one or more glucosylglycerides. 2. Cosmetic preparation according to claim 1, characterized in that one or more cationic emulsifiers are selected from the group of the compounds dimethyldioctadecylammonium chloride, dicocoylethylhydroxyethylmonium methosulfate, dicetyldimonium chloride, behentrimonium chloride, Laυryttήmoniυmchlorid, dipalmitoylethyldimonium chloride, N- (2-hydroxyhexadecyl-1) -N, N- dimethyl-N-2-hydroxyethylammonium chloride, distearoylethylhydroxyethylammonium methosulfate, tris (oligooxyethyl) alkylammonium phosphate, dicocoylethylhydroxyethylmonium methosulfate and / or cetyltrimethylammonium chloride. 3. Cosmetic preparation according to one of the preceding claims, characterized in that is used as a cationic emulsifier Dimethyldioctadecylammoniumchlorid. 4. Preparation according to one of the preceding claims, characterized in that the preparation glucosylglycerides in a total amount of 0.01 to 10% by weight based on the total weight of the preparation. 5. Preparation according to one of the preceding claims, characterized in that the preparation cationic emulsifiers in a total amount of 0.05 to 10 % By weight, based on the total weight of the preparation. 6. Preparation according to one of the preceding claims, characterized in that the preparation contains cationic polymers. 7. Preparation according to one of the preceding claims, characterized in that the preparation contains as cationic polymers one or more compounds selected from the group of compounds of cationic cellulose derivatives, cationic starch derivatives, quaternized vinylpyrrolidone / vinylimidazole copolymers. 8. Cosmetic preparation according to one of the preceding claims, characterized in that the preparation contains one or more further UV filters. Particularly advantageous UV filter substances which are liquid at room temperature for the purposes of the present invention are homomenthyl salicylate (INCI: homosalates), 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (INCI: octocrylene), terephthalidene dic- imheresulfonic acid; 2-Ethylhexyl 2-hydroxybenzoate (2-ethylhexyl salicylate, octyl salicylate, INCI: octyl salicylate) and esters of cinnamic acid, preferably 2-ethylhexyl 4-methoxycinnamate (2-ethylhexyl-4-methoxycinnamate, INCI: octyl methoxycinnamate) and 4-pentyl Methoxyzimtsäureiso- (isopentyl 4-methoxycinnamate, INCI: isoamyl p-methoxycinnamate), phenylene-1, 4-bis- (2-benzimidazyl) -3,3 ^I -5,5'-tetrasulfonsäuresalze; 2 Phenylbenzimidazole-5-sulfonic acid salts; 3- (4- (2,2-ethoxycarbonylvinyl) phenoxy) propenyl) -methoxysiloxane / dimethylsiloxane copolymer, which is available, for example, under the trade name Parsol® SLX from Hoffmann La Roche, 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl Triazine); Dioctylbutylamidotriazone (INCI: diethylhexyl-butamidotriazone); 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine having the (CAS no 288254-16-0); 2,4,6-tribiphenyl-4-yl-1,3,5-triazine; merocyanines; Titiandioxid; Zinc oxide in a concentration of 0.01 to 40% by weight and particularly preferably in a concentration of 1 to 20% by weight % based on the total weight of the preparation. 9. Cosmetic preparation according to one of the preceding claims, characterized in that the preparation as further ingredients one or more compounds selected from the group folic acid, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, natural and / or synthetic isoflavonoids, genistein . Flavonoids, carotenoids, creatine, creatinine, taurine, ascorbic acid and derivatives, oxygen, tocopherol + ester, dihydroxyacetone; long and short chain hyaluronic acid (i.e., hyaluronic acid having an average molecular weight of 1 million to 3 million daltons, as well as 5,000 daltons - 1 million daltons); 8-hexadecene-1, 16-dicarboxylic acid and / or licochalcone A contains.